Skip to content

Prevalence of ESBL-producing Enterobacteriaceae as Carbapenem-resistant Enterobacteriaceae in Nursing Homes.

Determination of the Prevalence of ESBL-producing Enterobacteriaceae as Carbapenem-resistant Enterobacteriaceae in Nursing Homes in Franche-Comté (France).

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03248999
Acronym
R'EHPAD
Enrollment
264
Registered
2017-08-15
Start date
2017-11-20
Completion date
2018-06-26
Last updated
2018-12-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Drug Resistance, Bacterial

Keywords

multidrug resistance, nursing home, ESBL, CRE

Brief summary

This study evaluates individual and collective factors of ESBL and CRE carriage in nursing homes.

Detailed description

Epimiological data concerning ESBL an CRE, may differ between nursing home and hospital or community but poor data are available. Multi-drug resistant bacteria carriage is associated with individual and collective factors wich have to be defined in nursing homes.

Interventions

DIAGNOSTIC_TESTrectal swab

stool samples by rectal swab

Sponsors

Centre Hospitalier Universitaire de Besancon
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* voluntary residents present in the institution on the study day

Exclusion criteria

* dement-wandering resident * unlikely to cooperate

Design outcomes

Primary

MeasureTime frameDescription
ESBL and CRE carriagethe day of the studynumber of residents colonized with a extented-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL) or carbapenem-resistant Enterobacteriaceae (CRE)

Secondary

MeasureTime frameDescription
patient and establishment factors associated with ESBL and CRE carriage with a questionnairethe day of the studyevaluation of risk factors associated with ESBL and CRE carriage and disseminationwith a questionnaire.

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026